1. Home
  2. XFOR
  3. XFOR News

Latest X4 Pharmaceuticals Inc. (XFOR) News on July 27, 2024

XFOR: Positive Interim Data from Ongoing Phase 2 Trial of Mavorixafor in Chronic Neutropenia Patients…

Zacks Small Cap Research

18 days ago

XFOR: Positive Interim Data from Ongoing Phase 2 Trial of Mavorixafor in Chronic Neutropenia Patients…

Associated Press Finance

3 months ago

X4 Pharmaceuticals: Q1 Earnings Snapshot

XFOR: XOLREMDI™ Approved by FDA…

Zacks Small Cap Research

3 months ago

XFOR: XOLREMDI™ Approved by FDA…

Thomson Reuters StreetEvents

4 months ago

Q4 2023 X4 Pharmaceuticals Inc Earnings Call

Zacks Small Cap Research

7 months ago

XFOR: Update on Phase 2 CN Trial at ASH 2023

Share on Social Networks: